ICT-107 is a DC vaccine consisting of autologous, monocyte-derived DCs pulsed with 6 well-known GBM TAAs, including melanoma-associated antigen 1, absent in melanoma 2, human epidermal growth factor receptor 2, tyrosinase-related protein 2, glycoprotein 100, and IL-13Rα2. This evidence concerns the gene IL13RA2 and glioblastoma.